RBP4 and metabolic dysfunction-associated steatotic liver disease: Moreover, according to a recent study, RBP4 induces hepatic steatosis because it activates primary inflammatory effects in adipose tissue and stimulates proinflammatory cytokines, such as TNF-α [37], while the suppression of RBP4 prevented NAFLD in mice models [38].